major unsolved problems in pharmaceutical drug development is the poor water solubility of many active pharmaceutical ingredients (APIs) and hence reduced bioavailability. Researchers have attempted to minimize the…
detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. Conventionally, it involves reporting individual cases or aggregate reports. Within the last decade…
drug efficacy, antibacterial properties and drug-polymer interactions. There are a number of different applications within medicine that require materials to be developed with the optimal characteristics, such as their…
then addition of drugs that have demonstrated single-agent activity, no-overlapping toxicity and additive or synergistic antineoplastic activity in an effort to develop a combination with improved efficacy
treatment of breast cancer patients. However, occurrence of drug resistance and other side effects highlights an unmet need to develop new potent therapeutic strategies. Nanoparticles (NPs) attracted a great deal…
challenge. Recent developments in the field of nanotechnology, including the use of inorganic materials, have opened up new dimensions. Mesoporous silica nanoparticles as drug carrier address many problems related
lead to abnormal growth i.e., development of cancer. Platinum complexes represent one of the most successful families of clinically used metal-based anticancer drugs; other transition metal complexes such
drugs being approved each year, and the increased costs associated with developing new drugs. At the same time, unprecedented advances in genomics, proteomics, molecular biology, and informatics have provided tremendous…
drug delivery, reduce toxicity to the patient, and thus improve therapeutic outcomes. Over time, nanoparticles have undergone evolution from simple to more complex systems, yet the nanoparticle formulations developed
MDM2 and its inhibitors at the 11th China-Japan Joint Symposium on Drug Design and Development. Although we showed a satisfactory result, we also thought the result could be improved
Iron deficiency Anemia (IDA) is a common global problem, particularly in the under-developed countries. The highest prevalence of IDA (60% to 80%) is seen in India, with about ... important to keep in consideration…
where available can be very costly especially in the developing countries. Hence there is neethat d to look for drugs from plant sources and are cost effective. This study therefore
increasing population of patients with HIV-1, and the increasing incidence of drug-resistant MTb strains. The existing BCG vaccine, shows a very low efficacy in preventing new infections ... Thus, MTb will pose an even…
Iron Deficiency Anemia (IDA) is a common global problem, particularly in the under-developed countries. The highest prevalence of IDA (60% to 80%) is seen in India, with about ... important to keep in consideration…
structural information derived from complexes of drug candidates with their protein targets to facilitate the discovery of safe and effective medicines. Despite recent developments in single particle cryo-electron…
acid substitutions affect a protein's stability can aid in the design of pharmaceutical drugs that aim to counter the deleterious effects caused by protein mutants. Although mutagenesis experiments performed…
amount of used thread should be quantified because the thread is actually the drug that should be quantified. Measuring the amount of used thread is inconvenient and bothersome ... sewing machine. All 4 animals were…
focus on the sodium glucose co-transporter 1 (hSGLT1) on which we plan to develop the methodologies that will be transferred on other systems, probably LeuT homologues. Mechanism of water ... Conclusion & Significance…
homeobox-1 (PDX1) transcription factor. PDX1 is important for beta cell maturation and pancreatic development. When phosphorylated however, it is ubiquitinated and degraded, which leads to beta-cell apoptosis resulting…
p38γ active-state complex may reveal the molecular features for the design of new drug against the progression of colorectal cancer. \ Recent Publications ... Meng T C, Hsu S F and Tonks N K (2005) Development of a…
drugs being approved each year, and the increased costs associated with developing new drugs. At the same time, unprecedented advances in genomics, proteomics, molecular biology, and informatics have provided tremendous…
drug delivery, reduce toxicity to the patient, and thus improve therapeutic outcomes. Over time, nanoparticles have undergone evolution from simple to more complex systems, yet the nanoparticle formulations developed
MDM2 and its inhibitors at the 11th China-Japan Joint Symposium on Drug Design and Development. Although we showed a satisfactory result, we also thought the result could be improved
worm to PZQ over very large foci. Th erefore, it is imperative to develop a new drug against this debilitating disease using the broad-spectrum therapeutic potentials of antimicrobial peptides ... whole, all generated…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.